Jounce Therapeu CVR Contra Cus
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Jounce Therapeu CVR Contra Cus in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Moloney Securities Asset Management, LLC ($0), Erste Asset Management GmbH ($0) and Crowley Wealth Management, Inc. ($0).
- Company
- Jounce Therapeu CVR Contra Cus
- Filed as
- CONTRA JOUNCE THERAPEUTI (Q1 2025)
- CUSIP
- 481CVR017
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 25,000 shares sold, net −25,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Moloney Securities Asset Management, LLC | 0.00% | Reduce -14.2% | 151,450 | $0 |
| Erste Asset Management GmbH | 0.00% | No change | 1,559,587 | $0 |
| Crowley Wealth Management, Inc. | 0.00% | No change | 1,300 | $0 |
"% of holder's portfolio" is JOUNCE THERAPEU CVR CONTRA CUS's weight in each manager's 13F, not the share of Jounce Therapeu CVR Contra Cus the manager owns.